Blood markers may predict heart attack severity
NCT ID NCT07149883
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether two blood markers – mean platelet volume (MPV) and the systemic inflammatory response index (SIRI) – can help diagnose and predict outcomes in people with acute coronary syndrome (heart attack or unstable angina). Researchers will measure these markers in 300 adults admitted within 24 hours of symptoms. The goal is to see if these simple tests can aid doctors in assessing heart risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to help doctors diagnose and predict outcomes in heart attack patients.
- What could go wrong
- This is an early observational study, not a treatment trial. The markers may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Ultrasound 'Memory' imaging may reveal hidden heart ischemia
- Can we predict which heart aneurysms will grow?